Xenon Pharmaceuticals (XENE) Preferred Dividend Payments (2013 - 2014)
Xenon Pharmaceuticals (XENE) posted quarterly Preferred Dividend Payments of $5.6 million for Q3 2014, up 10.61% year-over-year from $5.1 million in Q3 2013, and up 354.96% quarter-over-quarter from $1.2 million in Q2 2014.
Powered by 
Analysis
Xenon Pharmaceuticals (XENE) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Preferred Dividend Payments for 2 consecutive years, with $5.6 million the latest figure, recorded in Q3 2014.
- In Q3 2014, Preferred Dividend Payments rose 10.61% year-over-year to $5.6 million; the TTM figure through Sep 2014 stood at $8.2 million (changed N/A YoY), while the FY2013 annual figure was $8.2 million, changed N/A from the prior year.
- Preferred Dividend Payments climbed to $5.6 million in Q3 2014 per XENE's latest filing, from $1.2 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $5.6 million in Q3 2014 and bottomed at $1.2 million in Q2 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Xenon Pharmaceuticals | 5.96 Bn | 5.96 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 5.60 Mn |
| Jun 30, 2014 | 1.23 Mn |
| Mar 31, 2014 | 1.37 Mn |
| Sep 30, 2013 | 5.06 Mn |